Ankur Dhingra, Chief Financial Officer at Summit Therapeutics Inc. (SMMT), bought 100,000 shares at $3.75 ($375K) on 2024-03-26, disclosed to the SEC on 2024-03-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| SMMT | BUY | 2023-03-08 | $13K | — | Filing → |
| SMMT | BUY | 2023-03-08 | $412K | — | Filing → |
| SMMT | BUY | 2022-08-17 | $35K | — | Filing → |